SKAN Group AG

BATS-CHIXE:SKANZ Stock Report

Market Cap: CHF 1.7b

SKAN Group Valuation

Is SKANZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SKANZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SKANZ (CHF76.7) is trading below our estimate of fair value (CHF86.01)

Significantly Below Fair Value: SKANZ is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SKANZ?

Key metric: As SKANZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SKANZ. This is calculated by dividing SKANZ's market cap by their current earnings.
What is SKANZ's PE Ratio?
PE Ratio53.1x
EarningsCHF 32.24m
Market CapCHF 1.71b

Price to Earnings Ratio vs Peers

How does SKANZ's PE Ratio compare to its peers?

The above table shows the PE ratio for SKANZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average46.7x
ERGO Ergomed
46.7x14.2%UK£701.1m
HVO hVIVO
7.4x-29.6%UK£130.0m
C4XD C4X Discovery Holdings
2.9x-88.3%UK£30.3m
GNS Genus
129.7x31.5%UK£1.0b
SKANZ SKAN Group
53.1x17.8%CHF 1.7b

Price-To-Earnings vs Peers: SKANZ is expensive based on its Price-To-Earnings Ratio (53.1x) compared to the peer average (46.7x).

Price to Earnings Ratio vs Industry

How does SKANZ's PE Ratio compare vs other companies in the European Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
No. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SKANZ is expensive based on its Price-To-Earnings Ratio (53.1x) compared to the European Life Sciences industry average (38.2x).

Price to Earnings Ratio vs Fair Ratio

What is SKANZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SKANZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio53.1x
Fair PE Ratio23.4x

Price-To-Earnings vs Fair Ratio: SKANZ is expensive based on its Price-To-Earnings Ratio (53.1x) compared to the estimated Fair Price-To-Earnings Ratio (23.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SKANZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 76.70
CHF 90.67
+18.2%
2.9%CHF 93.00CHF 87.00n/a3
Dec ’25CHF 73.90
CHF 90.00
+21.8%
3.3%CHF 93.00CHF 87.00n/a2
Nov ’25CHF 78.90
CHF 90.00
+14.1%
3.3%CHF 93.00CHF 87.00n/a2
Oct ’25CHF 79.40
CHF 90.00
+13.4%
3.3%CHF 93.00CHF 87.00n/a2
Sep ’25CHF 80.70
CHF 97.50
+20.8%
10.8%CHF 108.00CHF 87.00n/a2
Aug ’25CHF 79.90
CHF 97.50
+22.0%
10.8%CHF 108.00CHF 87.00n/a2
Jul ’25CHF 80.00
CHF 97.50
+21.9%
10.8%CHF 108.00CHF 87.00n/a2
Jun ’25CHF 80.10
CHF 95.67
+19.4%
9.4%CHF 108.00CHF 87.00n/a3
May ’25CHF 81.90
CHF 91.33
+11.5%
15.2%CHF 108.00CHF 74.00n/a3
Apr ’25CHF 84.50
CHF 91.33
+8.1%
15.2%CHF 108.00CHF 74.00n/a3
Mar ’25CHF 82.70
CHF 91.33
+10.4%
15.2%CHF 108.00CHF 74.00n/a3
Feb ’25CHF 75.70
CHF 91.33
+20.7%
15.2%CHF 108.00CHF 74.00n/a3
Jan ’25CHF 80.90
CHF 91.33
+12.9%
15.2%CHF 108.00CHF 74.00CHF 76.703
Dec ’24CHF 78.10
CHF 91.33
+16.9%
15.2%CHF 108.00CHF 74.00CHF 73.903
Nov ’24CHF 70.00
CHF 91.33
+30.5%
15.2%CHF 108.00CHF 74.00CHF 78.903
Oct ’24CHF 77.40
CHF 91.00
+17.6%
18.7%CHF 108.00CHF 74.00CHF 79.402
Sep ’24CHF 79.60
CHF 92.33
+16.0%
15.2%CHF 108.00CHF 74.00CHF 80.703
Aug ’24CHF 79.60
CHF 100.50
+26.3%
5.5%CHF 106.00CHF 95.00CHF 79.902
Jul ’24CHF 76.80
CHF 100.50
+30.9%
5.5%CHF 106.00CHF 95.00CHF 80.002
Jun ’24CHF 80.30
CHF 100.50
+25.2%
5.5%CHF 106.00CHF 95.00CHF 80.102
May ’24CHF 86.00
CHF 94.00
+9.3%
12.8%CHF 106.00CHF 82.00CHF 81.902
Apr ’24CHF 84.00
CHF 94.00
+11.9%
12.8%CHF 106.00CHF 82.00CHF 84.502
Mar ’24CHF 69.00
CHF 86.50
+25.4%
22.5%CHF 106.00CHF 67.00CHF 82.702
Feb ’24CHF 69.00
CHF 86.50
+25.4%
22.5%CHF 106.00CHF 67.00CHF 75.702
Jan ’24CHF 63.20
CHF 86.50
+36.9%
22.5%CHF 106.00CHF 67.00CHF 80.902

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 10:28
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SKAN Group AG is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Leonildo DelgadoBaader Helvea Equity Research
Samuel EnglandBerenberg